by Jason Wasserman MD PhD FRCPC
April 10, 2026
HPV-associated dysplasia of the oral cavity is a precancerous condition in which the cells lining the inside of the mouth develop abnormal features due to infection with the human papillomavirus (HPV). The word dysplasia means that the cells have started to grow and behave abnormally — they are not cancer yet, but without treatment, they can progress to a type of oral cancer called squamous cell carcinoma over time.
Receiving this diagnosis means that an abnormal area was found in your mouth, a biopsy was taken, and the pathologist has identified precancerous changes driven by HPV. This is a serious finding that warrants treatment, but it is not cancer. When precancerous changes like these are identified and treated before they progress, the outcome is generally excellent.
HPV is a very common virus that infects squamous cells — the flat cells that line the surfaces of the mouth, throat, genitals, and other sites in the body. There are more than 100 types of HPV. Most cause no lasting harm and are cleared by the immune system on their own. However, certain high-risk types — particularly HPV 16 and HPV 18 — can persist in cells and disrupt the normal mechanisms that regulate cell growth and division.
Specifically, high-risk HPV produces proteins that block the function of tumor-suppressor proteins — the molecular brakes that normally prevent cells from dividing out of control. When these brakes are disrupted, cells begin to grow abnormally, and over time this can lead to dysplasia and eventually cancer. This is the same mechanism by which high-risk HPV causes precancerous changes in the oropharynx, cervix, and anal canal.
HPV is spread through direct skin-to-skin contact, including sexual contact and oral-genital contact. It is one of the most widespread viruses in the world — most sexually active adults will have at least one HPV infection during their lifetime. The vast majority of infections clear without causing any lasting changes. HPV-associated dysplasia of the oral cavity develops only in a small subset of people with persistent infection with a high-risk type.
Many people with HPV-associated dysplasia of the oral cavity have no symptoms at all, particularly in the early stages. This is one of the reasons regular dental and medical checkups are valuable — the condition may be identified before it causes any noticeable problems.
When symptoms are present, they may include:
Any patch or sore in the mouth that has not healed within two to three weeks should be evaluated by a dentist or doctor.
The diagnosis is made by a pathologist after a tissue sample is removed from the abnormal area. A doctor or dentist who notices an unusual patch or lesion in the mouth will perform a biopsy — a small procedure in which a sample of tissue is taken and sent to the pathology laboratory for examination.
In the laboratory, the pathologist examines the tissue under the microscope to assess the degree of cellular abnormality. In most cases, additional testing is performed to confirm that the dysplasia is driven by HPV rather than by other causes such as tobacco. These tests include:
Under the microscope, HPV-associated dysplasia of the oral cavity has a distinctive appearance. The squamous cells in the affected area show a range of abnormal features, including:
Unlike HPV-independent dysplasia, HPV-associated dysplasia of the oral cavity is not assigned a grade (mild, moderate, or severe). Research has shown that grading does not reliably predict cancer risk in HPV-associated lesions. For this reason, the focus is on the presence of the dysplasia itself — and on whether it has been completely removed — rather than on a specific grade.
p16 is a protein that acts as a brake on cell division. When cells are infected by high-risk HPV, the virus disables this brake, causing p16 to accumulate in large amounts throughout the cell. Pathologists detect this accumulation using immunohistochemistry. A strong, widespread positive p16 result in the dysplastic cells supports the diagnosis of HPV-associated dysplasia. If your report says the dysplasia is “p16 positive,” this confirms the HPV connection and is an expected finding for this diagnosis.
The margin is the edge of the tissue that was removed. Margin status is particularly important for a precancerous condition because it indicates whether all abnormal cells were removed.
HPV-associated dysplasia of the oral cavity is a precancerous condition, and without treatment it carries a real risk of progressing to squamous cell carcinoma over time. Studies to date suggest that approximately 10 to 15% of patients with this diagnosis will develop oral cavity cancer if the dysplasia is not completely removed.
Surgical excision — complete removal of the dysplastic area — is associated with a substantially lower risk of cancer and a better overall outcome. This is why complete removal with clear margins is the goal of treatment.
It is also worth knowing that HPV-associated oral cavity cancer, when it does develop, tends to respond better to treatment than HPV-independent oral cavity cancer. This is consistent with what is seen in HPV-associated cancers at other sites such as the oropharynx.
The primary treatment for HPV-associated dysplasia of the oral cavity is surgical removal — excision of the abnormal area with the goal of achieving clear margins. This is typically performed by an oral surgeon or a head and neck surgeon and is done as a minor procedure under local anesthesia in most cases.
After excision, follow-up is important. The specific schedule will depend on factors such as the margin status, the extent of the dysplasia, and your overall health and risk factors. In general:
Quitting smoking and reducing alcohol consumption — if applicable — are strongly recommended, as tobacco and alcohol are independent risk factors that can accelerate the progression of oral dysplasia to cancer.
For family members or close contacts who have not yet been vaccinated, it is worth knowing that the HPV vaccine is highly effective at preventing infection with the high-risk HPV types that cause dysplasia and cancer. While vaccination cannot treat an existing infection, it can protect uninfected individuals. Vaccination is most effective when given before exposure to HPV, typically in adolescence, but it is also recommended for adults up to age 26, and may benefit some adults up to age 45.